|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0016360,
umls-concept:C0205179,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1521750,
umls-concept:C1521991,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2239176,
umls-concept:C2911692
|
|
pubmed:issue |
18 Pt 1
|
|
pubmed:dateCreated |
2004-9-27
|
|
pubmed:abstractText |
The prognosis of hepatocellular carcinoma (HCC) is very poor, particularly in patients with tumors that have invaded the major branches of the portal vein. Combination chemotherapy with intra-arterial 5-fluorouracil and subcutaneous interferon-alpha has shown promising results for such advanced HCC, but it is important to develop the ability to accurately predict chemotherapeutic responses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:DonoKeizoK,
pubmed-author:IshiiShinS,
pubmed-author:KatoKikuyaK,
pubmed-author:KurokawaYukinoriY,
pubmed-author:MatobaRyoR,
pubmed-author:MondenMoritoM,
pubmed-author:NaganoHiroakiH,
pubmed-author:NakamoriShojiS,
pubmed-author:SakonMasatoM,
pubmed-author:TakemasaIchiroI,
pubmed-author:UenoNorikoN,
pubmed-author:UmeshitaKojiK
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6029-38
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15447987-Adult,
pubmed-meshheading:15447987-Aged,
pubmed-meshheading:15447987-Antimetabolites, Antineoplastic,
pubmed-meshheading:15447987-Antineoplastic Agents,
pubmed-meshheading:15447987-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15447987-Carcinoma, Hepatocellular,
pubmed-meshheading:15447987-Cluster Analysis,
pubmed-meshheading:15447987-Female,
pubmed-meshheading:15447987-Fluorouracil,
pubmed-meshheading:15447987-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15447987-Humans,
pubmed-meshheading:15447987-Interferon-alpha,
pubmed-meshheading:15447987-Liver Neoplasms,
pubmed-meshheading:15447987-Male,
pubmed-meshheading:15447987-Middle Aged,
pubmed-meshheading:15447987-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:15447987-Polymerase Chain Reaction,
pubmed-meshheading:15447987-Prognosis,
pubmed-meshheading:15447987-Time Factors,
pubmed-meshheading:15447987-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Molecular prediction of response to 5-fluorouracil and interferon-alpha combination chemotherapy in advanced hepatocellular carcinoma.
|
|
pubmed:affiliation |
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
